Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 383

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Evaluation of Antibodies to Hepatitis C Virus in a Study of Transfusion-Associated Hepatitis

Open access
Esteban, Juan I., González, Antonio, Hernández, José M., Viladomiu, Luis, Sánchez, Carmen, López-Talavera, Juan C., Lucea, David, Martin-Vega, Carmen, Vidal, Xavier, Esteban, Rafael, Guardia, Jaime · 1990 · New England Journal of Medicine

Abstract

BACKGROUND: The hepatitis C virus (HCV) is now known to be the chief cause of transfusion-associated non-A, non-B hepatitis, but the prevalence of HCV among blood donors and the frequency of transmission by blood transfusion are unknown. METHODS: To assess the sensitivity and specificity of a test for antibody to HCV, we tested serum samples from participants in a large study of transfusion-associated hepatitis. Samples were obtained prospectively from consecutive adults undergoing open-heart surgery in Spain, but were tested retrospectively, after the antibody enzyme immunoassay for anti-HCV became available. RESULTS: Of 280 transfusion recipients given a total of 1109 units of blood, 27 (9.6 percent) had transfusion-associated non-A, non-B hepatitis (mean follow-up, 52 weeks) and 24 of the 27 seroconverted to anti-HCV-positive, whereas only 2 (0.8 percent) of the remaining transfusion recipients seroconverted. Among the 1044 donor specimens available for testing, 16 (1.5 percent) had anti-HCV antibody. Only 1 additional seropositive donor was found when 44 implicated donors who had been seronegative were retested 9 to 12 months later. Of the 16 recipients of anti-HCV-positive blood, 14 (88 percent) had transfusion-associated hepatitis and seroconverted to anti-HCV-positive. The remaining two recipients had neither hepatitis nor anti-HCV antibody. Among 25 patients with non-A, non-B hepatitis for whom all transfused blood was tested, 14 had received blood positive for anti-HCV. CONCLUSIONS: About 90 percent of blood donors with antibody to HCV have infectious virus in their blood. The screening of blood donors for anti-HCV antibody should prevent about half the cases of transfusion-associated hepatitis, but the donors with infectious virus who are anti-HCV-negative may remain seronegative for prolonged periods.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199010183231605

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 383

Metadata

Authors
Esteban, J. I., González, A., Hernández, J. M., Viladomiu, L., Sánchez, C., López-Talavera, J. C., Lucea, D., Martin-Vega, C., Vidal, X., Esteban, R., & Guardia, J.
Venue
New England Journal of Medicine
Published
1990-10-18
Volume
323
Issue
16
Pages
1107-1112
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2339946342
Cited by
383
References
9
FWCI
43.87
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of Antibodies to Hepatitis C Virus in a Study of Transfusion-Associated Hepatitis. https://app.cochat.ai/papers/10.1056/nejm199010183231605
The paper
Esteban, J. I., González, A., Hernández, J. M., Viladomiu, L., Sánchez, C., López-Talavera, J. C., Lucea, D., Martin-Vega, C., Vidal, X., Esteban, R., & Guardia, J. (1990). Evaluation of Antibodies to Hepatitis C Virus in a Study of Transfusion-Associated Hepatitis. New England Journal of Medicine. https://doi.org/10.1056/nejm199010183231605

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.